date:Oct 29, 2012
The EU FibeBiotics project has announced two events that it says indicate the progress of the consortium.
The project studies the effect of non-digestible polysaccharides (NPS) on the gut and immune system of humans. The project started in January 2012 and will last for 4.5 years, receiving a EU support of 6m.
The first announcement is the start of the first human pilot trial. The trial design is a randomised double blind placebo controlled trial with six arms in which 240 (40 in each arm) eld